Business leaders
Pubblicato il 01-10-2026 - Pharming Group in Italia
This Tempo pieno on site position offers great opportunities for career growth. Italy ( remote/ Home-based) About the Role The Business Lead Italy will play a critical role in establishing and growing the Italian affiliate and preparing for the launch of the company's first ultra-orphan therapy planned for July 2027. Reporting to the General Manager Italy, Germany & Spain, you will lead cross-functional execution across Commercial, Market Access, Medical Affairs, and Operations, ensuring business priorities are translated into effective local action.
As the Italian business expands, the scope of the position is expected to evolve into broader affiliate leadership responsibilities. Field-Based Leadership (50%) A key element of the role is maintaining a strong presence in the field.
Business & Launch Leadership Lead and coordinate Italy's launch readiness and execution plans. Translate strategic priorities into actionable business plans. Drive cross-functional alignment across Commercial, Market Access, Medical Affairs, Regulatory, PV, and Supply Chain. Monitor business performance,
milestones, risks, and opportunities. Provide recommendations and business insights to the General Manager.
Gather market and healthcare system insights to inform strategy and execution. Commercial & Market Access Support development and execution of commercial and reimbursement strategies. Monitor market dynamics, access developments, and performance indicators.
Contribute to forecasting, business planning, and resource prioritization. Leadership & Collaboration Foster strong collaboration across local, regional, and global teams. Support recruitment, onboarding, and development of the Italian organization. Lead through influence and help build a high-performing, patient-focused culture. Compliance & Governance Ensure activities are conducted in line with applicable regulations, company policies, and ethical standards. Partner with Legal, Compliance, Quality, Regulatory, and Pharmacovigilan